✦ LIBER ✦

Correlation of pharmacokinetic data with endpoints of developmental toxicity

✍ Scribed by YOUNG, J

Book ID: 123211174
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 270 KB
Volume: 16
Category: Article
ISSN: 0272-0590
DOI: 10.1016/0272-0590(91)90105-D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tests for Trend in Developmental Toxicit

Tests for Trend in Developmental Toxicity Experiments with Correlated Binary Data

✍ K. Y. Fung; D. Krewski; J. N. K. Rao; A. J. Scott 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 750 KB

An analysis of genetic toxicity, reprodu

An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints

✍ Edwin J. Matthews; Naomi L. Kruhlak; Michael C. Cimino; R. Daniel Benz; Joseph F 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 624 KB

Atenolol: pharmacokinetic/dynamic aspect

Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity

✍ Sonia A. Tabacova; Carole A. Kimmel 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Correlation of clinical pharmacokinetic

Correlation of clinical pharmacokinetic parameters of cisplatin with efficacy and toxicity

✍ Desoize, B; Maréchal, F; Millart, H; Cattan, A 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 470 KB

Correlation of mechanistic data and hist

Correlation of mechanistic data and histopathology in the evaluation of selected toxic endpoints of the endocrine system

✍ Charles C Capen 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Approaches to the assessment of toxicity

Approaches to the assessment of toxicity data with endpoints related to endocrine disruption

✍ Philip W. Harvey; Ian Johnson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

There has been a substantial proliferation in the number of studies reporting endocrine effects as an endpoint. The vast majority have focused on oestrogenicity in vitro but, with recent recommendations by the USEPA Endocrine Disrupter Screening and Testing Advisory Committee, tests are now being de